Is Banner Display?
Off
Page Content
#ffffff

The 2023 European Society of Cardiology (ESC) guidelines for acute coronary syndromes (ACS) introduced several practice-changing recommendations. A registry-based retrospective study presented at the Heart Failure 2026 evaluated how implementation of these recommendations influenced real-world clinical practice and in-hospital outcomes.

The single-center analysis included 1,455 patients hospitalized with ACS who were enrolled in the Portuguese Registry of Acute Coronary Syndromes between October 2010 and July 2025. Patients were categorized as Group A (treated before guideline implementation; n= 1154) and Group B (treated after guideline implementation; n= 301). 

Findings

  • Patients treated after guideline implementation were younger (65.6 ± 12.9 vs 67.3 ± 12.7 years; p=0.043), more frequently smokers (30.2% vs 23.2%; p=0.012), and had higher rates of previous PCI (15.6% vs 10.8%; p=0.022).
  • STEMI admissions increased after guideline adoption (56.8% vs 45.4%; p<0.001).
  • Coronary angiography rates increased (99.7% vs 96.6%; p=0.004), along with PCI utilization (85.0% vs 76.8%; p=0.002) and staged PCI (28.9% vs 19.0%; p=0.002).
  • Among patients with non-ST-segment elevation myocardial infarction (NSTEMI), time to coronary angiography decreased from 36.8 to 18.7 hours (p<0.001).
  • In STEMI, fibrinolysis use declined (2.0% vs 11.6%; p<0.001), and pre-catheterization P2Y12 loading became less frequent (59.6% vs 85.1%; p<0.001).
  • In-hospital heart failure decreased (14.0% vs 21.0%; p=0.006), as did cardiogenic shock (1.3% vs 4.9%; p=0.006) and mechanical complications (0% vs 1.0%; p=0.035).
  • Mean hospital stay was shorter after guideline implementation (5 ± 3 vs 6 ± 4 days; p=0.003).
  • Referral to cardiac rehabilitation increased significantly (52.7% vs 16.9%; p<0.001).

In this real-world registry analysis, implementation of the 2023 ESC ACS guidelines was associated with substantial changes in invasive and pharmacologic management, accompanied by lower rates of several in-hospital complications and shorter hospitalization duration. 

Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
  • Implementation of the 2023 ESC ACS guidelines was associated with major changes in invasive management and antiplatelet use.
  • Rates of PCI, staged PCI, and radial access increased after guideline adoption.
  • In-hospital heart failure, cardiogenic shock, and mechanical complications decreased.
  • Hospital stay shortened, while in-hospital mortality remained unchanged.
     
Source

Heart Failure 2026, organized by the Heart Failure Association of the European Society of Cardiology; Barcelona, Spain.

Thumbnail
Guideline Adherence
Schedule Date & Time
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description

Portuguese ACS registry study (n=1,455) found greater PCI use, shorter NSTEMI angiography delays, and reduced in-hospital complications after guideline implementation.

Release Date
Is Paid
0
Send Notification
Off